About Onkolyze
Onkolyze is a company based in Singapore founded in 2018 by Vivek Sheraton Muniraj and Rory Wilding.. Onkolyze operates in a competitive market with competitors including Avenda Health, Onc.ai, Panakeia, Boston Medical Sciences and Nevia Bio, among others.
- Headquarter Singapore
- Founders Vivek Sheraton Muniraj, Rory Wilding
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Onkolyze Pte Ltd
-
Annual Revenue
$72.98 K (USD)358as on Apr 30, 2021
-
Net Profit
$20.44 K (USD)283as on Apr 30, 2021
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Onkolyze
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Onkolyze
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Onkolyze
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Onkolyze Comparisons
Competitors of Onkolyze
Onkolyze operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avenda Health, Onc.ai, Panakeia, Boston Medical Sciences and Nevia Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a focal therapy system to treat prostate cancer
|
|
| domain | founded_year | HQ Location |
AI platform aids cancer diagnosis and treatment for healthcare providers.
|
|
| domain | founded_year | HQ Location |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| domain | founded_year | HQ Location |
AI-powered colorectal cancer screening system
|
|
| domain | founded_year | HQ Location |
Machine learning-enabled platform for early detection of women-related diseases
|
|
| domain | founded_year | HQ Location |
Provider of platform for the detection of cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Onkolyze
When was Onkolyze founded?
Onkolyze was founded in 2018.
Where is Onkolyze located?
Onkolyze is headquartered in Singapore.
Who is the current CEO of Onkolyze?
Rory Wilding is the current CEO of Onkolyze. They have also founded this company.
What is the annual revenue of Onkolyze?
Annual revenue of Onkolyze is $72.98K as on Apr 30, 2021.
What does Onkolyze do?
Onkolyze was founded in 2018 in Singapore within the health technology sector. An AI-based platform is offered for cancer detection, where ultrasound images are automatically processed to segment regions of interest. Pre-populated reports adhering to the BI-RADS lexicon standard are generated from the analyzed data, supporting clinical workflows in oncology diagnostics.
Who are the top competitors of Onkolyze?
Onkolyze's top competitors include Onc.ai, Avenda Health and Panakeia.